Multiple Myeloma — Part 6 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Managing Ocular Toxicity in Multiple Myeloma Therapy
This chapter discusses the management of ocular toxicity linked to multiple myeloma treatments, emphasizing dosage strategies and patient monitoring. It features a case study on ibertamide, explores newer treatment options, and highlights the advantages of recent therapies over traditional methods.
Transcript
Play full episode
